Merck Aktie
106,55
EUR
+0,05
EUR
+0,05
%
Kursziele der Merck-Aktie in EUR
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Merck-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| JP Morgan Chase & Co. | 150,00 EUR | +41,18% | 16.03.2026 | |
| Barclays Capital | 130,00 EUR | +22,35% | 12.03.2026 | |
| Goldman Sachs Group Inc. | 153,00 EUR | +44,00% | 09.03.2026 | |
| Deutsche Bank AG | 125,00 EUR | +17,65% | 09.03.2026 | |
| DZ BANK | - | - | 06.03.2026 | |
| UBS AG | 150,00 EUR | +41,18% | 05.03.2026 | |
| Bernstein Research | 135,00 EUR | +27,06% | 17.11.2025 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| 3M Co. | 0 | 0 | 0 | - | - |
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 7 | 1 | 1 | 165,75 GBP | - |
| BASF | 5 | 3 | 2 | 50,00 EUR | - |
| Bayer | 5 | 4 | 1 | 39,67 EUR | - |
| BB Biotech AG | 0 | 0 | 0 | - | - |
| Beiersdorf AG | 4 | 5 | 2 | 100,60 EUR | - |
| Biotest AG Vz. | 0 | 0 | 0 | - | - |
| Bristol-Myers Squibb Co. | 0 | 0 | 0 | - | - |
| Clorox | 0 | 0 | 0 | - | - |
| Colgate-Palmolive Co. | 0 | 0 | 0 | - | - |
| Eli Lilly | 1 | 0 | 0 | 1145,00 USD | +27,65% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| GSK PLC Registered Shs | 2 | 5 | 2 | 19,80 GBP | -2,75% |
| H. B. Fuller Co. | 0 | 0 | 0 | - | - |
| H&R GmbH & Co. KGaA | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| L'Oréal S.A. (L'Oreal, L Oreal) | 5 | 4 | 1 | 397,67 EUR | - |
| LANXESS AG | 2 | 5 | 2 | 16,94 EUR | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 4 | 3 | 0 | 140,50 EUR | - |
| Novartis AG | 3 | 5 | 1 | 116,88 CHF | -2,06% |
| Pfizer Inc. | 1 | 5 | 0 | 28,33 USD | +2,76% |
| Procter & Gamble Co. | 1 | 0 | 0 | 177,00 USD | +24,28% |
| Reckitt Benckiser Plc | 3 | 4 | 0 | 58,75 GBP | - |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 5 | 4 | 0 | 97,62 EUR | - |
| STADA | 0 | 0 | 0 | - | - |
| Takeda Pharmaceutical Co. Ltd. | 0 | 0 | 0 | - | - |
| Unilever PLC | 5 | 2 | 3 | - | - |
| WACKER CHEMIE AG | 3 | 3 | 2 | 80,67 EUR | - |